Crosslinking (CXL) provides a stiffer cornea. A significant change in endothelial cell density after CXL has not been reported. There is a synergistic effect in the combination of ICRS and CXL ...
The study also found no significant changes in intraocular pressure or anterior chamber depth, with the mean change in corneal endothelial cell density at six months being -280.7 cells/mm².
AURN001 is a combination cell therapy product candidate comprised of allogeneic human corneal endothelial cells (neltependocel) and a rho kinase inhibitor (Y-27632). This investigational product ...
One-year data of high-fluence accelerated epithelium-off corneal cross-linking for keratoconus showed efficacy comparable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback